Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07568730
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep 4 μM Ophthalmic Solution in Subjects With Neurotrophic KeratitisTearSolutions, Inc.RecruitingPhase 2
NCT07568730Recruiting
Phase 2
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study...TearSolutions, Inc.
NCT07569965
Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCLMiltenyi Biomedicine GmbHNot Yet RecruitingPhase 2
NCT07569965Not Yet Recruiting
Phase 2
Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation i...Miltenyi Biomedicine GmbH
NCT07570251
Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving ChemotherapySaglik Bilimleri UniversitesiCompletedNot Applicable
NCT07570251Completed
Not Applicable
Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving...Saglik Bilimleri Universi...
NCT07571031
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell CarcinomaFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07571031Not Yet Recruiting
—
Inter-Operator Variability in the Clinical Staging and Therapeutic Management of...Fondazione Policlinico Un...
NCT07569575
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone FracturesHuaMg Perfection Med Tech (Suzhou) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07569575Not Yet Recruiting
Not Applicable
Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone FracturesHuaMg Perfection Med Tech...
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 2
NCT07570173Not Yet Recruiting
Phase 2
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (...Merck Sharp & Dohme LLC
NCT07568691
Comparing Whole-Body Vibration vs. Balance Board Exercise for Pain, Function, and Quality of Life in Obese Adults With Knee OsteoarthritisIndonesia UniversityCompletedNot Applicable
NCT07568691Completed
Not Applicable
Comparing Whole-Body Vibration vs. Balance Board Exercise for Pain, Function, an...Indonesia University
NCT07570134
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei UniversityNot Yet RecruitingNot Applicable
NCT07570134Not Yet Recruiting
Not Applicable
Simulation-Based Interprofessional Education for Operating Room TeamsYonsei University
NCT07569523
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNot Yet Recruiting
NCT07569523Not Yet Recruiting
—
Development of Preterm Infants Born During the COVID-19 PandemicFundació Institut de Rece...
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07571668
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07571668Not Yet Recruiting
Not Applicable
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International Univ...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07569055
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell TransplantationFirst Affiliated Hospital of Guangxi Medical UniversityRecruiting
NCT07569055Recruiting
—
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoie...First Affiliated Hospital...
NCT07569224
Testing the Impact of the MOHR Follow-up SupportNational Cancer Institute (NCI)RecruitingNot Applicable
NCT07569224Recruiting
Not Applicable
Testing the Impact of the MOHR Follow-up SupportNational Cancer Institute...
NCT07570017
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaGuangzhou Lupeng Pharmaceutical Company LTD.Not Yet RecruitingPhase 1
NCT07570017Not Yet Recruiting
Phase 1
A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refrac...Guangzhou Lupeng Pharmace...
NCT07571213
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National Cohort of 315 042 ICU AdmissionsRegion DalarnaCompleted
NCT07571213Completed
—
Pre-ICU Hospital Length of Stay and 30-day Mortality in the Very Old: a National...Region Dalarna
NCT07569120
In Vivo Noradrenergic System and AgingHospices Civils de LyonNot Yet RecruitingNot Applicable
NCT07569120Not Yet Recruiting
Not Applicable
In Vivo Noradrenergic System and AgingHospices Civils de Lyon
NCT07571148
Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT UsersBristol-Myers SquibbActive Not Recruiting
NCT07571148Active Not Recruiting
—
Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilizati...Bristol-Myers Squibb
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Completed4 (20%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified6 (30%)
Phase 24 (20%)
Phase 11 (5%)